The isolated antibody binds specifically to HER2, the pharmaceuticals and therapeutic agents containing this antibody, and the nucleic acid molecule encoding this antibody.

VN10062134BActive Publication Date: 2026-11-02ONO PHARMA CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
VN1202303336
Authority / Receiving Office
VN · VN
Patent Type
Patents
Current Assignee / Owner
Filing Date
2021-11-29
Publication Date
2026-11-02
Estimated Expiration
2041-11-29
Patent Text Reader

Abstract

The invention proposes an antibody or its antigenic fragment that binds to HER2 and is expressed on cancer cells, or a fragment of HER2, an HER2-targeted substance containing any of these, and a pharmaceutical composition containing an HER2-targeted substance.
Need to check novelty before this filing date? Find Prior Art